Glioblastoma Treatment Market Expected to Reach USD 0.91 Billion in 2022

According to a new market report published by Transparency Market Research Pipeline Review of Glioblastoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022, the global glioblastoma treatment market was valued at USD 0.34 billion in 2013 and is estimated to reach USD 0.91 billion by 2022 at a CAGR of 11.4% from 2014 to 2022.Glioblastoma multiforme (GBM), also categorized as high-grade glioma, is the most aggressive astrocytic tumor, composed of poorly differentiated neoplastic astrocytes (subtype of central nervous system cells). The pipeline analysis of the GBM treatment market has been segmented on the basis of type of drug and geography. Three drugs that cover the major market of GBM treatment are bevacizumab (Avastin), temozolomide (Temodar/Temodal/Temcad), and carmustine (BiCNU). Regions covered in the geography segment include North America, Europe, Asia Pacific, and Rest of the World (RoW).

Browse the full Pipeline Review of Glioblastoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 report at http://www.transparencymarketresearch.com/pipeline-review-of-glioblastoma-treatment-market.html

The FDA approved treatments for GBM comprises carmustine, temozolomide, and bevacozumab. Carmiustine drug is brand named as Gliadel (Arbor Pharmaceuticals, LLC) which is a surgical implant, while bevacozumab (Brand name Avastin, product of Genetech/Roche) is targeted for intravenous therapy and temozolomide (Temodar/Temodal/Temcad and other brands) is recommended for intravenous or oral chemotherapy. The factors driving the glioblastoma treatment market include rising awareness against various types of brain tumors, research and development in drug delivery technologies and combination of modern diagnostic techniques. In 2013, temozolomide dominated the global glioblastoma market due to the therapeutic benefit of alkylated/methylated DNA, which most often occurs at the N-7 or O-6 positions of guanine residues. In 2012, the drug had lost its exclusivity and lead to the entry of generic drugs in the market, thereby, reducing the market share globally.

Geographically, in 2013 North America dominated the global glioblastoma market owing to rising incidences of glioblastoma multiforme (GBM) coupled with increasing number of associations such as American Brain Tumor Association, National Brain Tumor Society, Brain Tumor Foundation of Canada and others engaged in raising awareness for GBM in the region. In addition, majority of the manufacturers developing drugs for the treatment of glioblastoma are domiciled in the region thereby, supporting the dominance of the North America market. Asia Pacific is the most lucrative regional market for glioblastoma due to rising awareness against GBM which is boosting the diagnostic rate in Asia Pacific and developing healthcare infrastructure by upgrading the diagnostic and treatment facilities in Asia Pacific.

Browse the full Press relaese Report :

http://www.transparencymarketresearch.com/pressrelease/pipeline-review-of-glioblastoma-treatment-market.htm

Merck & Co., Inc., F. Hoffmann-Le Roche AG, and Arbor Pharmaceuticals, LLC are the key players dominated the global GBM treatment market in 2013. The other generic drug manufacturers present in the global glioblastoma market are Teva Pharmaceutical Industries, Ltd., Amneal Pharmaceuticals. LLC, Sun Pharmaceutical Industries, Ltd., amongst others.

The pipeline review of glioblastoma treatment market has been segmented as below:

Global Glioblastoma Treatment Market Revenue and Forecast, by Drugs

Bevacizumab (Avastin)

Temozolomide (Temodar and Temodal and Temcad)

Carmustine (BiCNU)

Global Glioblastoma Treatment Market Revenue and Forecast, by Geography

North America

Europe

Asia Pacific

Rest of the World

Global Pipeline Review of Glioblastoma Treatment

Overview

Late Stage (Phase III)

DCVax

Rindopepimut (CDX-110)

Others

Early Stage (Phase I, II and Pre clinical)

ABT-414

MM-398

ARC-100

AV0113

Cotara

Crenolanib

SGT-53

Endostatin

ANG1005

Others

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4807

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Germany Expected to be the Fastest Growing Heparin Market in Europe Expanding at a CAGR of 6.0% by 2022

According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022” the Europe heparin market was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.

Browse the full Heparin Market (Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 report at http://www.transparencymarketresearch.com/europe-heparin-market.html

The heparin market in Europe has been categorized into major national markets namely, the United Kingdom, Germany, Spain, Italy, France, and Rest of Europe. The European market is among the major contributors to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. In the current scenario, according to the 2015 Ageing Report by the European Commission, the percentage of population aged above 65 years is expected to increase from 21% in 2013 to 32% in 2060. As aging is proportional to increasing incidences of VTE diseases such as deep vein thrombosis (DVT) and pulmonary embolism (PE) demand for heparin is expected to increase in coming years.

Germany accounts for the largest market share in the overall Europe heparin market accounting for around 274.8 million in 2013. Key attributes to the market growth in Germany encompasses burgeoning population of venous thromboembolism (VTE) patients owing to which the consumption of heparin has grown at a rapid pace over the past few years. Moreover, ban of Chinese APIs due to adulterated issue leading to over 100 deaths in the U.S., has drastically attracted new players in heparin processing and manufacturing business. For instance in 2013, German meat company Tönnies group acquired heparin API manufacturer Pharma Action which proposed to manufacture 30 metric tons of API in forthcoming years. For instance, Germany-based meat company Tönnies Group entered the heparin processing business by acquiring heparin API maker Pharma Action. Such developments are expected to augment heparin market in Germany.

Followed by Germany, France has major contribution to the heparin market in the Europe. Each year 370,000 deaths in France occur due to VTE. Moreover, Heparin consumption during and after surgical procedures such as knee replacement, hip surgeries, appendectomy and breast surgeries are relatively high compared to Italy, Spain and United Kingdom. It is estimated that every fourth person in France by 2020 would be aged above 60 years. Rapidly aging population and growing life expectancy would increase the risk of thrombosis among the geriatric population. According to the Thrombosis Research Institute, around 25,000 deaths occur annually in England due to hospital-contracted VTE. Based on the recommendations from the chief medical officer (CMO), the Department of Health in the U.K. published an operating framework for the NHS in England. This framework requires risk assessment to be done for thrombosis in a minimum of 90% of patients admitted to hospitals. All these factors are likely to support the growth in demand for heparin for prophylaxis and treatment of thrombosis during the forecast period.

Browse the full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/geography-heparin-market.htm

Spain, Italy and Rest of the Europe markets although have low revenue contribution in European heparin market is expected to grow in forthcoming years. Spain's National Institute of Statistics (INE) predicts that the Spanish population would shrink by 5.6 million before 2064. Additionally, about 40% of the population would be aged over 65 years, which is an increase from 18.2% in 2013. The United Nations (UN) projects that Spain would be the world’s oldest country by 2050. This is a major factor attributed to an increased risk of thrombosis, which would further propel demand for heparin in the region. Such factors along with increasing investment in elderly care would propel the demand for heparin in Italy. As of 2014, there is only one drug licensed (Rivaroxaban; Xarelto) for the treatment of VTE in Italy. Advent of biosimilars would augment the growth of heparin market in Italy during the forecast period. Some of the key players profiled in this report include Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Leo Pharma A/S, Pfizer, Inc., Sanofi S.A., and Syntex S.A. are profiled in this report.

 

The Europe Heparin Market is segmented into the following categories:

Europe Heparin Market, by Product

Unfractionated Heparin

Low Molecular Weight Heparin (LMWHs)

Ultra-low Molecular Weight Heparin (ULMWHs)

Europe Heparin Market, by Country

United Kingdom

Unfractionated Heparin

Low Molecular Weight Heparin (LMWHs)

Ultra-low Molecular Weight Heparin (ULMWHs)

Germany

Unfractionated Heparin

Low Molecular Weight Heparin (LMWHs)

Ultra-low Molecular Weight Heparin (ULMWHs)

France

Unfractionated Heparin

Low Molecular Weight Heparin (LMWHs)

Ultra-low Molecular Weight Heparin (ULMWHs)

Spain

Unfractionated Heparin

Low Molecular Weight Heparin (LMWHs)

Ultra-low Molecular Weight Heparin (ULMWHs)

Italy

Unfractionated Heparin

Low Molecular Weight Heparin (LMWHs)

Ultra-low Molecular Weight Heparin (ULMWHs)

Rest of the Europe

Unfractionated Heparin

Low Molecular Weight Heparin (LMWHs)

Ultra-low Molecular Weight Heparin (ULMWHs)

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4815

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market to Reach INR 1,390.2 Crore in 2020

According to a new market report published by Transparency Market Research “Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market - India Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020” the sterilizers and surgical, dental care and equipment disinfectors market in India was valued at INR 806.0 Crore in 2013 and is estimated to reach a market worth of INR 1,390.2 Crore in 2020 increasing at a CAGR of 8.2% from 2014 to 2020.

Rising incidence of hospital acquired infectious diseases and increase in the number of surgeries in hospitals is expected to drive the sterilizers and surgical, dental care, and equipment disinfectors market in India. Factors that drive the growth of the sterilization equipment and disinfectants market in India are large pool of geriatric population, rise in prevalence of cancer and increasing number of hospital-acquired infections (HAIs). Furthermore, increase in per capita healthcare expenditure would also propel the growth of this market. According to Trading Economics, disposable personal income in India increased to approximately INR 80,663,730 million in 2012 from INR 71,787,870 million in 2011. Additionally, the market is likely to witness steady growth in technological advancements such as introduction of radiation-based sterilization techniques (gamma and E-beam sterilization) during the forecast period due to high product compatibility and low cost. Negligence towards sterilization measures in hospitals might restrain market growth. Moreover, increasing acceptance of single use and disposable medical device is another major restraint to the chemical sterilizers market.

sterilizers-surgical-dental-care-equipment-disinfectors-market

Government measures to provide adequate healthcare services in remote parts of nation have substantially increased the number of hospitals in the last few years. Furthermore, growing medical tourism in India is also driving the market growth. To further elucidate, heart bypass surgery in India costs USD 5,200 (approx. INR 3.3 Lakhs) while it costs USD 144,000 (Approx. INR 91 Lakhs) in the U.S. Low treatment cost in India is attracting patients across the world and is expected to drive growth of the sterilizers and surgical, dental care, and equipment disinfectors market during the forecast period. According to an article published by the Times of India in September 2014, India is among the top three medical tourism destinations in Asia, primarily due to low cost of treatment, availability of highly skilled specialists, and sophisticated health care infrastructure. However, growing inclination towards single use and disposable instruments due to its consistency and safety has affected the India sterilizers and surgical, dental care and equipment disinfectors market in last few years.

Chlorhexidine gluconate, alcohol, povidone-iodine, benzalkonium chloride, octenidine hydrochloride, ethyl-hexadecyl-dimethyl ammonium and others (aldehydes, hydrogen peroxide, hypochlorites and chlorine based disinfectors) collectively form the chemical formulations market; among which chlorhexidine gluconate based formulations accounted for the largest market share and is expected to lead the position during the forecast period due to the high safety, better efficacy and high usage adoption rate among hospitals and patients. Similarly, within the general hospitals application segment usage of chemical sterilizers and disinfectors were observed to be highest in wound care. Increasing number surgical procedures and rising number of trauma cases are few of the major factors that are boosting the application of sterilizers and disinfectors in wound care segment. Furthermore, within end-users segment operating rooms, ICUs and nursing tables segment accounted for the largest market share and is anticipated to lead the market during the forecast period due to high usage of chemical disinfectors used for disinfecting the equipment used during surgeries. Similarly, within the surgery stages segment post-operative surgery stage account for the largest market share due to the due to increasing risk of infection caused by a number of microbes, their growing drug resistance, and extended hospital stay after the surgery.

Key players profiled in this research report include 3M, Advanced Sterilization Products Services, Inc., Antrix Hygiene Ltd., Ipca Laboratories Ltd., Medi-Vet Animal Health, LLC, PSK Pharma Private Limited, Raman & Weil Pvt. Ltd., Ranbaxy Laboratories Ltd., Reckitt Benckiser Group plc, Sanosil Biotech Pvt. Ltd., Schülke India Pvt. Ltd., UPS Hygienes Pvt. Ltd., Win-Medicare Pvt. Ltd., and Zep Superior Solutions. The end-users (hospitals) profiled in this study are Apollo Hospitals Enterprise Ltd., Fortis Healthcare Limited, and Wockhardt Hospitals.

Browse the full Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market (By Chemical Formulations, By Applications, By End-users & By Surgery Stages) India Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/sterilizers-surgical-dental-care-equipment-disinfectors-market.html

The India sterilizers and surgical, dental care and equipment disinfectors market is segmented into the following categories:

 

Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Chemical Formulations

Chlorhexidine Gluconate Based Formulations

Alcohol Based Agents

Povidone-Iodine Based Formulations

Benzalkonium Chloride Based Formulations

Octenidine Hydrochloride Based Formulations

Ethyl - hexadecyl - dimethyl Ammonium Based Formulations

Others (Aldehydes, Hydrogen Peroxide, Hypochlorites and Chlorine Based Disinfectors)

Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Applications

Hospitals

General Hospitals

Wound Care

Burn Care

Ulcer Care

Dental Care Centers

Surgical Care

Diagnostic Care

Veterinary Care Centers

Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by End-users

Patients and Caregivers

Hospital and Nursing Staff

Operating Rooms, ICUs and Nursing Tables

Equipment and Devices used during Surgery

Others (Veterinary and Diagnostic Care Centers)

Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Surgery Stages

Pre-operative

Intra-operative

Post-operative

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4681

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

 Website: http://www.transparencymarketresearch.com/

Collagen Peptide and Gelatin Market: APAC to Emerge as Most Lucrative Region Owing to Rising Health Awareness

Surging awareness about physiological well-being and personal healthcare drives the growth of the global collagen peptide and gelatin market, states a recently published report by Transparency Market Research. The report is titled “Collagen Peptide and Gelatin Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2014 - 2020” and is available for sale on the company website.According to the report, the global collagen peptide market is poised to grow from US$0.7 billion in 2013 to US$1.1 billion in 2020, registering a 6.8% CAGR during the forecast period. The gelatin market, on the other hand, was worth US$1.8 billion in 2013 and is estimated to be worth US$3.0 billion by 2020, developing at a 7.5% CAGR from 2014 to 2020.

Browse the full Collagen Peptide and Gelatin Market Report at http://www.transparencymarketresearch.com/collagen-peptide.html

The collagen peptide and gelatin market is segmented on the basis of type of sources, applications, and geography. Geographically, the global collagen peptide and gelatin market is divided into North America, Europe, Asia Pacific, and Rest of the World. Owing to the increased popularity of cosmeceuticals, rise in R&D activities, and growing awareness about nutraceuticals, North America dominated the collagen peptide market in 2013. The gelatin market, however, was led by Europe owing to flourishing pharmaceutical and food and beverages industries and presence of several research organizations in the field of nutritional products. The Asia Pacific market for collagen peptide and gelatin is set to be the most promising regional segment from 2014 to 2020 owing to rising importance of nutrition and personal well-being and steady pace of industrialization.

The key sources of gelatin are chicken, porcine, marine, bovine, and others such as donkey, horse, cat, and dog. The major applications areas of gelatin are pet food, cosmeceuticals, food and beverages, ballistics, bone and joint health, pharmaceuticals, nutraceuticals, photography, and India ink. Porcine gelatin led the global market, with marine gelatin likely to register the highest CAGR over the forecast period. By application, the use of gelatin in the food and beverages segment held the largest share of the market, with bone and health being the fastest growing application segment from 2014 to 2020.Marine collagen peptide was the largest as well as the most rapidly developing segment in 2013 and is estimated to retain its lead during the course of the forecast period. Cosmeceuticals was the dominant segment of the collagen peptide market in terms of application and it held a 20% share in the global market. However, the use of collagen peptide in applications such as wound healing and regenerative medicine will be the fastest growing segment by 2020.

Browse the full Press Release Report :

http://www.transparencymarketresearch.com/pressrelease/collagen-peptide.htm

The collagen peptide and gelatin market is rather consolidated, with a select few players dominating the global market. The major players featured in the collagen peptide and gelatin market report are ChinaTech Peptide Co. Ltd., Nitta Gelatin, Inc., Sterling Gelatin, BioCell Technology LLC, InterHealth Nutraceuticals, Inc., Capsugel Belgium NV, Roxlor LLC, Weishardt International Group, GELITA AG, Norland Products, Inc., Pont Brule (PB) Gelatins GmbH, Amicogen, Inc., Catalent, Inc., and Rousselot International. Among these, GELITA AG dominated by gelatin market in 2013, while Rousselot International led the collagen peptide market the same year.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1070

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

G-Protein Coupled Receptors (GPCRs) Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022

This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an elaborate executive summary, which includes a market snapshot providing overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global GPCRs market with respect to the leading market segments based on types of products, applications and geographic regions.

Browse Full G-Protein Coupled Receptors (GPCRs) Market Report With Complete TOC @

http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html

The global GPCRs market has been segmented based on of assay type, therapeutic area, and geography. Based on assay type, the GPCRs market has been categorized into six major segments: cAMP assays, calcium level detection assays, GTPγS binding assays, reporter gene assays, receptor internalization assays, and cGMP assays. The market for these segments has been extensively analyzed based on of their effectiveness, usefulness, sales, and geographic presence. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

In terms of therapeutic areas, the market has been segmented into seven categories: cardiovascular system, central nervous system (CNS), respiratory system, immune system, reproductive system, oncology, and others (abdominal, urinary, orthopedics, etc.). Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that have strong impact on the GPCRs market currently and could influence the market in future as well. The market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Porter’s Five Forces analysis is also explained in this section to understand the GPCRs market considering different parameters that have an impact on the sustainability of the companies operating in the GPCRs market. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Browse Full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/g-protein-coupled-receptors-market.htm

Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Major geographic regions have been further divided into major national markets, viz. North America (the U.S. and Canada), Europe (Germany, the U.K., France, and Rest of Europe), and Asia Pacific (China, Japan, India, and Rest of Asia Pacific). Moreover, Rest of the World has been further subdivided into three regions: Latin America, the Middle East, and Africa. Market revenue in terms of USD million for the period between 2012 and 2022 along with the CAGR % from 2014 to 2022 are provided for all the regional and national markets considering 2013 as the base year.

The recommendations section included in the report would assist existing market players in expanding their market shares and new companies in establishing their presence in the global market. The report also profiles major players in the GPCRs market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., EMD (Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays, Enzo Life Sciences, Inc., DiscoveRx Corporation, Sigma-Aldrich Corporation, QIAGEN N.V., Promega Corporation, Abcam plc, and HD Biosciences Co. Ltd.

The global GPCRs market is segmented as follows:

GPCRs Market, by Assay Type

Calcium Level Detection Assays

GTPγS Binding Assays

cGMP Assays

Reporter Gene Assays

Receptor Internalization Assay

cAMP Assays

GPCRs Market, by Therapeutic Area

Cardiovascular System

Central Nervous System

Respiratory System

Immune System

Reproductive System

Oncology

Others

GPCRs Market, by Geography

North America

U.S.

Canada

Europe

U.K.

Germany

France

Rest of Europe

Asia Pacific

China

Japan

India

Rest of Asia Pacific

Rest of the World (RoW)

Latin America

Middle East

Africa.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=550

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Asia Pacific Region to Dominate the Global FMD Vaccines Market

Transparency Market Research has released a new report on the global foot and mouth disease (FMD) vaccines market, which forecasts the growth of the overall FMD vaccines market at a CAGR of 8.8% during the period from 2014 to 2020. The FMD vaccines market was valued at US$0.51 billion in 2013. Due to the increasing frequency of FMD outbreaks, the report projects that the market will reach a worth of US$0.95 billion by the end of 2020. The report is titled ‘Foot and Mouth Disease Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020’.

Browse the full Foot and Mouth Disease Vaccines Market Report at http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html

Caused by Aphthovirus, FMD is highly infectious viral disease which affects cloven-hoofed animals and leads to high mortality rate among the young stock such as lambs and piglets. The high prevalence of FMD across the globe affects the international trade in livestock products. The report provides an overview of the overall global FMD vaccines market and evaluates the growth drivers and restraints. Favorable government initiatives to control FMD outbreaks have boosted the growth of the global FMD vaccines market. Also, rising consumption of meat and dairy products demands healthy livestock, which has further fuelled the need for FMD vaccines. The report mentions that the involvement by various governments in purchasing FMD vaccines will lead to the dip in cost which will negatively affect the global FMD vaccines market in terms of revenue. FMD is caused by seven different types of serotype and the current vaccines are serotype-specific. Unpredictable serotype outbreaks can hamper the growth of the global FMD vaccines market. The report indicates that DNA vaccines will open new opportunities for the market during the forecast period.

Depending upon the type of vaccines, the report segments the global FMD vaccines market into conventional vaccines and emergency vaccines. The conventional vaccines have been further categorized into aluminum hydroxide or Saponin based vaccines, and oil-based vaccines. In 2013, oil-based FMD vaccines dominated the global FMD vaccines market with a market share of 63%, owing to its high efficiency and longer effect in treating the disease.

On the basis of application on the livestock, the global FMD vaccines market has been divided into cattle, pigs, sheep and goats, and others. To meet the increasing demand for milk and meat, cattle are reared the most across the globe, owing to which it has emerged as the largest application segment of the global FMD vaccines market. In Middle-east, as pork consumption is prohibited, the cattle segments contribute significantly to the FMD vaccines market of the region. The report predicts that the cattle segment will exhibit the fastest growth during the forecast horizon.

Browse the full Press Release Report:

http://www.transparencymarketresearch.com/pressrelease/foot-mouth-disease-vaccines.htm

Geographically, the global FMD vaccines market has been segmented into four key regions: Europe, North America, Asia Pacific, and Rest of the World. As the disease is non-existent in North America and Europe, the scope of the growth of the vaccines market in these regions is negligible. Due to frequent outbreaks of FMD in Asia Pacific region, the global FMD vaccines market has been dominated by this region with more than 70% share. The report documents the market revenue in China, India, Malaysia, South Korea, and rest of APAC during the forecast period. The report profiles some of the key vendors of the global FMD vaccines market such as Indian Immunologicals Ltd., Bayer AG, Agrovet Co., and Brilliant Bio Pharma Ltd.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2480

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Asia Pacific Region to Dominate the Global FMD Vaccines Market

Transparency Market Research has released a new report on the global foot and mouth disease (FMD) vaccines market, which forecasts the growth of the overall FMD vaccines market at a CAGR of 8.8% during the period from 2014 to 2020. The FMD vaccines market was valued at US$0.51 billion in 2013. Due to the increasing frequency of FMD outbreaks, the report projects that the market will reach a worth of US$0.95 billion by the end of 2020. The report is titled ‘Foot and Mouth Disease Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020’.

Browse the full Foot and Mouth Disease Vaccines Market Report at http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html

Caused by Aphthovirus, FMD is highly infectious viral disease which affects cloven-hoofed animals and leads to high mortality rate among the young stock such as lambs and piglets. The high prevalence of FMD across the globe affects the international trade in livestock products. The report provides an overview of the overall global FMD vaccines market and evaluates the growth drivers and restraints. Favorable government initiatives to control FMD outbreaks have boosted the growth of the global FMD vaccines market. Also, rising consumption of meat and dairy products demands healthy livestock, which has further fuelled the need for FMD vaccines. The report mentions that the involvement by various governments in purchasing FMD vaccines will lead to the dip in cost which will negatively affect the global FMD vaccines market in terms of revenue. FMD is caused by seven different types of serotype and the current vaccines are serotype-specific. Unpredictable serotype outbreaks can hamper the growth of the global FMD vaccines market. The report indicates that DNA vaccines will open new opportunities for the market during the forecast period.

Depending upon the type of vaccines, the report segments the global FMD vaccines market into conventional vaccines and emergency vaccines. The conventional vaccines have been further categorized into aluminum hydroxide or Saponin based vaccines, and oil-based vaccines. In 2013, oil-based FMD vaccines dominated the global FMD vaccines market with a market share of 63%, owing to its high efficiency and longer effect in treating the disease.

On the basis of application on the livestock, the global FMD vaccines market has been divided into cattle, pigs, sheep and goats, and others. To meet the increasing demand for milk and meat, cattle are reared the most across the globe, owing to which it has emerged as the largest application segment of the global FMD vaccines market. In Middle-east, as pork consumption is prohibited, the cattle segments contribute significantly to the FMD vaccines market of the region. The report predicts that the cattle segment will exhibit the fastest growth during the forecast horizon.

Browse the full Press Release Report:

http://www.transparencymarketresearch.com/pressrelease/foot-mouth-disease-vaccines.htm

Geographically, the global FMD vaccines market has been segmented into four key regions: Europe, North America, Asia Pacific, and Rest of the World. As the disease is non-existent in North America and Europe, the scope of the growth of the vaccines market in these regions is negligible. Due to frequent outbreaks of FMD in Asia Pacific region, the global FMD vaccines market has been dominated by this region with more than 70% share. The report documents the market revenue in China, India, Malaysia, South Korea, and rest of APAC during the forecast period. The report profiles some of the key vendors of the global FMD vaccines market such as Indian Immunologicals Ltd., Bayer AG, Agrovet Co., and Brilliant Bio Pharma Ltd.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2480

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com